1
|
Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, Haricharan S, Kavuri SM, Matsunuma R, Schmidt C, Kosaka Y, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Rodrigues-Peres RM, Lai WC, Hampton O, Rogers A, Tobias E, Parikh P, Davies S, Ma C, Suman V, Hunt K, Watson M, Hoadley KA, Thompson A, Perou CM, Creighton CJ, Maher C, Ellis MJ. Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-pd8-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. Dysregulation of the estrogen receptor gene (ESR1) is an established mechanism of inducing endocrine therapy resistance. We previously discovered a chromosomal translocation event generating an estrogen receptor gene fused in-frame to C-terminal sequences of YAP1 (ESR1-YAP1) that contributed to endocrine therapy resistance in estrogen receptor positive (ER+) breast cancer models. This study compares functional, transcriptional, and pharmacological properties of additional ESR1 gene fusion events of both early stage (ESR1-NOP2) late stage (ESR1-YAP1 and ESR1-PCDH11x) breast cancers to gain a better understanding of therapeutic resistance and metastasis. Understanding the role of ESR1 fusions in inducing metastasis is critical, since the primary cause of death in breast cancer patients is through metastasis to distant sites.
Methods. RNA-seq screens identified ESR1 fusions from early and late stage, endocrine therapy resistant breast tumor samples. Functional experiments were conducted using ER+ breast cancer cell lines, xenograft, and PDX models to test the ability of ESR1 fusions to induce therapeutic resistance and metastasis. ChIP-seq and RNA-seq were performed to examine transcriptional properties and differential gene expression induced by the fusions which directed subsequent pharmacological experiments with a CDK4/6 inhibitor.
Results. ESR1-YAP1 and ESR1-PCDH11x promoted estrogen-independent and fulvestrant-resistant growth in vitro and induced greater tumor growth and increased metastatic capacity to the lungs of xenografted mice. In contrast, the ESR1-NOP2 fusion was sensitive to low estrogen conditions in vitro, and did not promote tumor growth. RNA-seq profiling revealed E2F targets pathway as the most highly enriched pathway induced by the ESR1 fusions. IHC revealed higher levels of pRb in ESR1-YAP1 and ESR1-PCDH11x xenograft tumors and subsequent CDK4/6 inhibition completely blocked tumor growth in an ESR1-YAP1 PDX model. Integrating RNA-seq with ChIP-seq data, we discovered a set of EMT and metastasis genes bound by all ESR1 fusions and WT-ER, but whose expression was strongly and uniquely up-regulated only by the ESR1-YAP1 and ESR1-PCDH11x fusions. These studies also revealed gained sites bound only by the ESR1-YAP1 and ESR1-PCDH11x fusions, not bound by WT-ER nor ESR1-NOP2. Genes mapping to these sites have a role in metastatic biology and were highly up-regulated by the YAP1 and PCDH11x fusions, potentially mediated by long range transcriptional activation.
Conclusion. ESR1-YAP1 and ESR1-PCDH11x are driver fusions that occur in drug-resistant, advanced stage breast cancer and are a new class of recurrent somatic mutation that can cause acquired endocrine therapy resistance, yet can be treated with CDK4/6 inhibition. These driver fusions also confer increased metastatic ability through their ability to drive expression of genes that contribute to EMT and metastasis. In contrast, ESR1-NOP2 did not produce functional protein and appears to be a passenger event. These studies may provide pre-clinical rationale for targeting ESR1 translocated breast tumors, since the presence of an ESR1 driver fusion places a patient in a therapeutic category where none of the currently available endocrine therapies are likely to be effective.
Citation Format: Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, Haricharan S, Kavuri SM, Matsunuma R, Schmidt C, Kosaka Y, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Rodrigues-Peres RM, Lai W-C, Hampton O, Rogers A, Tobias E, Parikh P, Davies S, Ma C, Suman V, Hunt K, Watson M, Hoadley KA, Thompson A, Perou CM, Creighton CJ, Maher C, Ellis MJ. ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr PD8-03.
Collapse
Affiliation(s)
- JT Lei
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - J Shao
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - J Zhang
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - M Iglesia
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - DW Chan
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - J Cao
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - M Anurag
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - P Singh
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - S Haricharan
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - SM Kavuri
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - R Matsunuma
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - C Schmidt
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - Y Kosaka
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - R Crowder
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - J Hoog
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - C Phommaly
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - R Goncalves
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - S Ramalho
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - RM Rodrigues-Peres
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - W-C Lai
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - O Hampton
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - A Rogers
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - E Tobias
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - P Parikh
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - S Davies
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - C Ma
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - V Suman
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - K Hunt
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - M Watson
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - KA Hoadley
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - A Thompson
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - CM Perou
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - CJ Creighton
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - C Maher
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| | - MJ Ellis
- Baylor College of Medicine, Houston, TX; Washington University, St. Louis, MO; University of North Carolina; Kitasato University School of Medicine, Japan; University of Sao Paulo School of Medicine, Brazil; State University of Campinas, Brazil; Mayo Clinic; MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
2
|
Lei JT, Shao J, Zhang J, Iglesia M, Cao J, Chan DW, He X, Kosaka Y, Schmidt C, Matsunuma R, Haricharan S, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Lai WC, Hampton O, Rogers A, Tobias E, Parikh P, Davies S, Ma C, Suman V, Hunt K, Watson M, Hoadley KA, Thompson A, Chen X, Perou CM, Creighton CJ, Maher C, Ellis MJ. Abstract PD2-03: Recurrent functionally diverse in-frame ESR1 gene fusions drive endocrine resistance in breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-pd2-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. We previously reported an alternative ESR1 somatic gain-of-function chromosomal translocation event in a patient presenting with aggressive, endocrine therapy resistant estrogen receptor (ER) positive disease, producing an in-frame fusion gene consisting of N-terminal ESR1 and the C-terminus of the Hippo pathway coactivator YAP1 (ESR1-YAP1). We recently identified another ESR1 fusion through RNA sequencing (RNA-seq) in advanced stage ER+ disease from a chest wall recurrence in a male patient that was refractory to multiple lines of treatment. Two examples of fusions discovered in primary breast cancer samples include ESR1 fused in-frame to C-terminal sequences from NOP2 (ESR1-NOP2), identified in a resistant cohort from a RNA-seq screen focused on 81 primary breast cancers from aromatase inhibitor clinical trials, and a second ESR1 fusion, fused in-frame to the entire coding sequence of POLH (ESR1-POLH), that was identified from RNA-seq analysis of 728 Cancer Genome Atlas breast samples. This current study extends our previous characterization of ESR1-YAP1 by comparing functional and pharmacological properties of these three additional ESR1 gene fusion events of both early stage and advanced breast cancers.
Methods. In vitro and in vivo experiments were conducted to test ESR1 fusions to induce therapeutic resistance, and metastasis. The transcriptional and binding properties of each fusion was also examined. Pharmacological inhibition with Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, was utilized to assess drug sensitivity in ESR1 fusion containing breast cancer cells and in a patient derived xenograft (PDX) model expressing ESR1-YAP1 (WHIM18).
Results. The YAP1 and PCDH11x fusions conferred estrogen-independent and fulvestrant-resistant growth. Immunohistochemistry revealed significantly higher numbers of ER+ cells in lungs of mice xenografted with T47D cells expressing the YAP1 and PCDH11x fusions compared to YFP control, NOP2 and POLH fusions. Results from ChIP-seq and microarray studies suggest that these two fusions promote proliferation and metastasis through genomic action by binding estrogen response elements (ERE) and subsequent gene activation. We thereby define these fusions as “canonical” fusions compared to “non-canonical” NOP2 and POLH fusions, which demonstrated dramatically decreased genomic binding ability. The non-canonical fusions induced genes associated with basal-like breast cancer and promoted HER2, EGFR, and MAPK gene expression signatures in contrast to genes associated with cell cycle/proliferation induced by canonical fusions. The proliferative ability of canonical fusion-containing ER+ cells was inhibited by Palbociclib in a dose-dependent manner. In vivo WHIM18 tumors in mice fed with Palbociclib-containing chow demonstrated significantly reduced tumor volume, growth rate, and weight compared to tumors in mice on control chow.
Conclusions. In-frame ERE activating canonical fusions occur in end-stage drug resistant advanced breast cancer and can be added to ESR1 point mutations as a class of recurrent somatic mutation that may cause acquired resistance. Growth induced by these fusions can be antagonized by Palbociclib and is potentially clinically helpful.
Citation Format: Lei JT, Shao J, Zhang J, Iglesia M, Cao J, Chan DW, He X, Kosaka Y, Schmidt C, Matsunuma R, Haricharan S, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Lai W-C, Hampton O, Rogers A, Tobias E, Parikh P, Davies S, Ma C, Suman V, Hunt K, Watson M, Hoadley KA, Thompson A, Chen X, Perou CM, Creighton CJ, Maher C, Ellis MJ. Recurrent functionally diverse in-frame ESR1 gene fusions drive endocrine resistance in breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr PD2-03.
Collapse
Affiliation(s)
- JT Lei
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - J Shao
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - J Zhang
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - M Iglesia
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - J Cao
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - DW Chan
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - X He
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - Y Kosaka
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - C Schmidt
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - R Matsunuma
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - S Haricharan
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - R Crowder
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - J Hoog
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - C Phommaly
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - R Goncalves
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - S Ramalho
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - W-C Lai
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - O Hampton
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - A Rogers
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - E Tobias
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - P Parikh
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - S Davies
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - C Ma
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - V Suman
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - K Hunt
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - M Watson
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - KA Hoadley
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - A Thompson
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - X Chen
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - CM Perou
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - CJ Creighton
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - C Maher
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| | - MJ Ellis
- Baylor College of Medicine, Houston, TX; Washington University School of Medicine, St. Louis, MO; University of North Carolina, Chapel Hill, NC; Kitasato University School of Medicine, Minato, Japan; University of Sao Paulo School of Medicine, Sao Paulo, Brazil; State University of Campinas, Sao Paulo, Brazil; Mayo Clinic, Rochester, MN; MD Anderson Cancer Center, Houston, TX
| |
Collapse
|